A patient-driven agenda for liver cirrhosis research

Gut · Published 2026-07-27 · DOI 10.1136/gutjnl-2026-339715

Authors (7)

Oliver Tavabie, Helen Crisp, Cameron Griffiths, Richard Allen, Adam Ashborn, Vanessa Hebditch, Gautam Mehta

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Tavabie, O., Crisp, H., Griffiths, C., et al. (2026). A patient-driven agenda for liver cirrhosis research. Gut. https://doi.org/10.1136/gutjnl-2026-339715

Related articles

• A retrospective validation of a federated machine learning framework (Hepa-FedBoost) for improving liver cancer computed tomography diagnosis across heterogeneous hospital networks · Intelligent Medicine · 2025 · Cites or is cited by this article
• International consensus on intestinal epithelial barrier assessment and therapeutic effects in inflammatory bowel diseases clinical trials · Gut · 2026 · Same journal
• Toward a CKLM framework for integrated clinical trial design · Gut · 2026 · Same journal
• Large language models for detecting colorectal polyps in endoscopic images—further research is required · Gut · 2026 · Same journal
• USP20 promotes CD8 + T cell exhaustion and impairs KRAS G12D inhibitor efficacy by orchestrating cholesterol metabolism and autophagy in pancreatic cancer · Gut · 2026 · Same journal
• Galectin-14, a primate-specific oncofetal protein, impairs anti-tumour immunity in hepatocellular carcinoma by driving elevated heparan sulphate modification · Gut · 2026 · Same journal
• Cancer neuroscience in cholangiocarcinoma: from perineural invasion to neuroimmune control · Gut · 2026 · Same journal
• Cryptogenic steatotic liver disease: a lean phenotype associated with increased liver-related mortality · Gut · 2026 · Same journal
• Safety and efficacy of extended surveillance intervals following colorectal endoscopic submucosal dissection: an international multicentre study · Gut · 2026 · Same journal
• Enhanced acetate uptake and metabolism in endothelial cells promote tumour angiogenesis and immunosuppression by increasing histone acetylation · Gut · 2026 · Same journal